Unusual Blood Clots Characterized in Leprosy Patients
|
By LabMedica International staff writers Posted on 03 Apr 2018 |

Image: A histopathology of a deep vein inflammatory infiltrate with wall dissociated by edema, observed in a skin lesion of a leprosy patient suffering an erythema nodosum leprosum episode (Photo courtesy of Oswaldo Cruz Institute).
Leprosy is a chronic infection by Mycobacterium leprae and causes body-wide symptoms, deformities, and disability. It remains a public health problem worldwide, despite the existence of antibiotic combinations that can cure it.
Hemostatic disorders are frequently associated with acute and chronic infections due to the fact that platelet functions, blood coagulation and fibrinolysis are intimately correlated with the immune system. For years, doctors have observed that some patients with leprosy develop unusual blood clots, which can lead to stroke or heart attack.
Scientists at the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) analyzed two groups of patients: a prospective group, which plasma samples were collected before multidrug therapy against leprosy, composed of 11 non-reactional (multibacillary leprosy; MB-NR), being 10 lepromatous leprosy (LL) and one borderline lepromatous (BL). The erythema nodosum leprosum patients group (MB-ENL) included 13 LL and one BL individuals. These two groups include six females, 19 males with median age of 45.2 years, ranging from 23 to 80. The retrospective cohort was composed of 638 leprosy outpatients at an Outpatient Unit, from 2012 to 2014, where 35 patients presented the leprosum clot during serum harvesting.
The team performed SDS-PAGE and protein content was measured with the commercially available 2D Quant-Kit. Spots were taken from the gel, digested with trypsin and analyzed by spectrometry using the MALDI-TOF/TOF 5800. The mass spectrometry protein identifications were obtained with a 5800 Proteomics Analyzer.
The scientists applied the STA-R Evolution instrument to determine partial thromboplastin time (aPPT) and prothrombin time (PT) in all plasma samples. The levels of von Willebrand and soluble tissue factor, C4 complement, and anti-cardiolipin IgM antibody in the serum of leprosy patients were determined using the following commercial kits: Human von Willebrand Factor ELISA kit and Human Tissue Factor ELISA kit and C4 turbiquest, respectively.
The team found that patients both experiencing a reactional episode and those with non-reactional leprosy had factors in their blood, including plasmatic fibrinogen, anti-cardiolipin antibodies, von Willebrand factor, and soluble tissue factor, promoting blood coagulation. Formation of leprosum clots, they showed, was correlated with increased levels of soluble tissue factor and von Willebrand factor. Tests on leprosum clots revealed high contents of lipids and fibrinogen, and showed higher levels of two proteins, complement component 3 and 4 and inter-alpha- trypsin inhibitor family heavy chain-related protein (IHRP), compared to clots from patients without leprosy.
The authors propose that multibacillary patients with high levels of fibrinogen could be beneficiated from a prophylactic use of xanthine derivatives such as pentoxifylline, in order to prevent some of the acute clinical symptoms observed during severe cases of leprosy reactional episodes, such as cyanosis and tissue necrosis, probably related with superficial vein thrombosis. The study was published on March 22, 2018, in the journal PLOS Neglected Tropical Diseases.
Related Links:
Oswaldo Cruz Institute
Hemostatic disorders are frequently associated with acute and chronic infections due to the fact that platelet functions, blood coagulation and fibrinolysis are intimately correlated with the immune system. For years, doctors have observed that some patients with leprosy develop unusual blood clots, which can lead to stroke or heart attack.
Scientists at the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) analyzed two groups of patients: a prospective group, which plasma samples were collected before multidrug therapy against leprosy, composed of 11 non-reactional (multibacillary leprosy; MB-NR), being 10 lepromatous leprosy (LL) and one borderline lepromatous (BL). The erythema nodosum leprosum patients group (MB-ENL) included 13 LL and one BL individuals. These two groups include six females, 19 males with median age of 45.2 years, ranging from 23 to 80. The retrospective cohort was composed of 638 leprosy outpatients at an Outpatient Unit, from 2012 to 2014, where 35 patients presented the leprosum clot during serum harvesting.
The team performed SDS-PAGE and protein content was measured with the commercially available 2D Quant-Kit. Spots were taken from the gel, digested with trypsin and analyzed by spectrometry using the MALDI-TOF/TOF 5800. The mass spectrometry protein identifications were obtained with a 5800 Proteomics Analyzer.
The scientists applied the STA-R Evolution instrument to determine partial thromboplastin time (aPPT) and prothrombin time (PT) in all plasma samples. The levels of von Willebrand and soluble tissue factor, C4 complement, and anti-cardiolipin IgM antibody in the serum of leprosy patients were determined using the following commercial kits: Human von Willebrand Factor ELISA kit and Human Tissue Factor ELISA kit and C4 turbiquest, respectively.
The team found that patients both experiencing a reactional episode and those with non-reactional leprosy had factors in their blood, including plasmatic fibrinogen, anti-cardiolipin antibodies, von Willebrand factor, and soluble tissue factor, promoting blood coagulation. Formation of leprosum clots, they showed, was correlated with increased levels of soluble tissue factor and von Willebrand factor. Tests on leprosum clots revealed high contents of lipids and fibrinogen, and showed higher levels of two proteins, complement component 3 and 4 and inter-alpha- trypsin inhibitor family heavy chain-related protein (IHRP), compared to clots from patients without leprosy.
The authors propose that multibacillary patients with high levels of fibrinogen could be beneficiated from a prophylactic use of xanthine derivatives such as pentoxifylline, in order to prevent some of the acute clinical symptoms observed during severe cases of leprosy reactional episodes, such as cyanosis and tissue necrosis, probably related with superficial vein thrombosis. The study was published on March 22, 2018, in the journal PLOS Neglected Tropical Diseases.
Related Links:
Oswaldo Cruz Institute
Latest Immunology News
- Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice
- Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
- Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
- Exhaled Breath Particles Reveal Virus-Specific Antibodies in the Lower Airways
- Roche Gains FDA Clearance for Flexible Respiratory Pathogen Panel
- Tumor and Immune Biomarkers Linked to Treatment Response in T-Cell Lymphoma
- Prototype Point-of-Care Lateral Flow Test Aims to Improve Neonatal Sepsis Triage
- Compact Immunoanalyzer Gains CE Mark for Testing Across Local Care Settings
- COVID-19 and Flu Combo Test Launches With FDA Clearance
- Immune and Inflammatory Markers May Help Assess CAR T-Cell Complication Risk
- Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis
- Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk
- Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood
- Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia
- FDA Approval Adds Automated Testing Option for Parvovirus B19 Serology
- Blood-Based Immune Aging Map Could Help Spot Disease Risk Earlier
Channels
Clinical Chemistry
view channel
Study Questions Uniform Stool-Test Cutoff Across Age Groups
Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more
Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine
Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more
Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research
Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more
Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk
Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read moreMolecular Diagnostics
view channelGenome Sequencing Provides Clues to Unexplained Recurrent Miscarriages
Recurrent pregnancy loss, defined as two or more miscarriages, affects about 5% of couples. In many cases, routine evaluation does not identify a cause, particularly when pregnancies have a normal chromosome... Read more
Genetic Test Improves Risk Prediction for Open-Angle Glaucoma
Glaucoma damages the optic nerve and is the leading cause of irreversible blindness worldwide. Because the disease often causes no early symptoms, about half of affected individuals remain undiagnosed... Read moreHematology
view channel
Werfen Gains FDA Clearance for ROTEM sigma Cartridge Use in Trauma
Traumatic injuries account for approximately 10% of deaths worldwide, with uncontrolled bleeding remaining a leading cause of potentially preventable trauma-related death. Trauma-induced coagulopathy further... Read more
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Acute myeloid leukemia (AML) is an aggressive blood cancer affecting approximately 2,700 people in the U.K. annually, with only about one in six patients surviving five years after diagnosis.... Read moreImmunology
view channel
Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice
Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read morePathology
view channel
AI Prostate Cancer Test Added to NCCN Guidelines for Post-Surgery Recurrence
Following radical prostatectomy, an estimated 20% to 40% of prostate cancer patients develop biochemical recurrence, marked by rising prostate-specific antigen levels that may indicate cancer recurrence.... Read more
New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Review Highlights Progress and Validation Needs for AI in Digital Pathology
Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read moreTechnology
view channel
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read more
Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring
Clinical laboratories analyze blood, urine, tissue, and other bodily fluids to support disease diagnosis and treatment. Rising test volumes, workforce shortages, and increasingly complex diagnostics are... Read moreIndustry
view channel
Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil
Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more







